Novozymes A/S (OTCMKTS:NVZMY) Stock Price Crosses Below Two Hundred Day Moving Average - Here's What Happened

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report)'s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $63.12 and traded as low as $56.37. Novozymes A/S shares last traded at $56.58, with a volume of 17,813 shares trading hands.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on NVZMY. Barclays upgraded shares of Novozymes A/S to a "strong-buy" rating in a report on Monday, November 18th. Citigroup downgraded shares of Novozymes A/S from a "neutral" rating to a "sell" rating in a research note on Thursday, October 17th. Finally, Berenberg Bank upgraded shares of Novozymes A/S to a "strong-buy" rating in a report on Tuesday, September 24th.

Novozymes A/S Stock Performance

The stock's 50-day simple moving average is $58.70 and its 200 day simple moving average is $63.10. The company has a market capitalization of $26.49 billion, a PE ratio of 35.80, a P/E/G ratio of 3.87 and a beta of 0.87.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.